This study aims to test a new medicine called cemsidomide (CFT7455) to see if it's safe and effective for people with certain types of cancer: Non-Hodgkin's Lymphoma (NHL) and Multiple Myeloma (MM). These are both types of blood cancers. Cemsidomide is taken as a pill, and sometimes it will be given with another medicine called dexamethasone for MM patients. The study will look at how the body processes the drug (pharmacokinetics) and how it affects the cancer (pharmacodynamics).
People who want to join must be at least 18 years old, have a confirmed diagnosis of NHL or MM, and have tried other treatments that didn’t work. They also need to have good organ function.
- Length of Study: The study has multiple phases and may require long-term participation.
- Compensation: Patients may receive compensation for their participation.
- Risks: Potential side effects include those related to cancer treatments and the study drug.
How understandable was the trial content above?
Hard to understand
Easy to understand